Abstract
Materials and Methods: Simulated QSM maps were generated to assess the performance of the ICF method over a range of vein geometries with varying echo times and noise levels. The ICF method was also applied to in vivo human brain data to assess the feasibility and behavior of OEF measurements compared to the maximum intensity voxel (MIV) method.
Results: Improved quantification of OEF measurements was achieved for vessels with contrast to noise greater than 3.0 and vein radii greater than 0.75 voxels. The ICF method produced improved quantitative accuracy of OEF measurement compared to the MIV approach (mean OEF error 7.7 vs. 12.4%). The ICF method provided estimates of vein radius (mean error <27%) and partial volume maps (root mean-squared error <13%). In vivo results demonstrated consistent estimates of OEF along vein segments.
Conclusion: OEF quantification in small veins (1.5–4 voxels in diameter) had lower error when using partial volume estimates from the ICF method.
| Original language | English |
|---|---|
| Article number | 89 |
| Number of pages | 12 |
| Journal | Frontiers in Neuroscience |
| Volume | 11 |
| DOIs | |
| Publication status | Published - 27 Feb 2017 |
Keywords
- Partial volume
- Vein
- Oxygen extraction fraction
- OEF
- Quantitative susceptibility mapping
- QSM
- MRI
Projects
- 1 Finished
-
ARC Centre of Excellence for Integrative Brain Function
Egan, G. (Primary Chief Investigator (PCI)), Rosa, M. (Chief Investigator (CI)), Lowery, A. (Chief Investigator (CI)), Stuart, G. (Chief Investigator (CI)), Arabzadeh, E. (Chief Investigator (CI)), Skafidas, E. S. (Chief Investigator (CI)), Ibbotson, M. (Chief Investigator (CI)), Petrou, S. (Chief Investigator (CI)), Paxinos, G. (Chief Investigator (CI)), Mattingley, J. (Chief Investigator (CI)), Garrido, M. (Chief Investigator (CI)), Sah, P. K. (Chief Investigator (CI)), Robinson, P. A. (Chief Investigator (CI)), Martin, P. (Chief Investigator (CI)), Grunert, U. (Chief Investigator (CI)), Tanaka, K. (Partner Investigator (PI)), Mitra, P. (Partner Investigator (PI)), Johnson, G. (Partner Investigator (PI)), Diamond, M. (Partner Investigator (PI)), Margrie, T. (Partner Investigator (PI)), Leopold, D. (Partner Investigator (PI)), Movshon, J. (Partner Investigator (PI)), Markram, H. (Partner Investigator (PI)), Victor, J. (Partner Investigator (PI)), Hill, S. (Partner Investigator (PI)) & Jirsa, V. K. (Partner Investigator (PI))
Australian National University (ANU), Eidgenössische Technische Hochschule Zürich (ETH Zürich) (Federal Institute of Technology Zurich), ARC - Australian Research Council, Karolinska Institutet (Karolinska Institute), Council of the Queensland Institute of Medical Research (trading as QIMR Berghofer Medical Research Institute), Ecole Polytechnique Federale de Lausanne (EPFL) (Swiss Federal Institute of Technology in Lausanne) , Monash University, University of Melbourne, University of New South Wales (UNSW), University of Queensland , University of Sydney, Monash University – Internal University Contribution, NIH - National Institutes of Health (United States of America), Cornell University, New York University, Francis Crick Institute, Scuola Internazionale Superiore di Studi Avanzati (International School for Advanced Studies), Duke University, Cold Spring Harbor Laboratory, RIKEN
25/06/14 → 31/12/21
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver